Axillary lymphangioma that developed following COVID-19 vaccination: a case report

BACKGROUND: Extensive vaccination programs are being implemented worldwide for coronavirus disease 2019 (COVID-19). With the spread of vaccination, swelling of the lymph nodes after vaccination is frequently seen. We encountered a patient who developed left axillary lymphadenoma following vaccine ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasa, Soichiro, Inoue, Hiroaki, Inui, Tomohiro, Miyamoto, Naoki, Aoyama, Mariko, Okumura, Kazumasa, Toba, Hiroaki, Yoshida, Takahiro, Tezuka, Miki, Hirose, Chieko, Saijo, Yasuyo, Uehara, Hisanori, Izumori, Ayumi, Takahashi, Masako, Sasa, Mitsunori, Takizawa, Hiromitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263008/
https://www.ncbi.nlm.nih.gov/pubmed/35798903
http://dx.doi.org/10.1186/s40792-022-01488-5
Descripción
Sumario:BACKGROUND: Extensive vaccination programs are being implemented worldwide for coronavirus disease 2019 (COVID-19). With the spread of vaccination, swelling of the lymph nodes after vaccination is frequently seen. We encountered a patient who developed left axillary lymphadenoma following vaccine administration. CASE PRESENTATION: The patient was a Japanese woman in her 80 s who had previously undergone surgery for right breast cancer. She received two injections of the Pfizer-BioNTech COVID-19 vaccine in her left arm. Approximately 3 months later, she complained of left axillary swelling, and imaging resulted in a diagnosis of left axillary lymphangioma. In accordance with the patient’s wishes, we performed axillary mass resection. The pathological diagnosis was lymphangioma. CONCLUSION: Our examination findings indicated that congestion of the axillary lymph vessels might have been caused by upper-arm injections of the COVID-19 vaccine.

Ejemplares similares